The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease
Abstract
Neuropsychiatric symptoms (NPS) of Parkinson's disease (PD) are of growing diagnostic and therapeutic importance. Data on their prevalence and characteristics have been primarily derived from highly selective clinical populations. We have conducted a national study in the outpatient care sector to provide a fuller characterization of the frequency of dementia, depression, and other NPS in PD outpatients. We also examined associations with biosocial and neurological variables. A nationwide representative sample of 1,449 PD outpatients was examined with a standardized clinical interview. PD severity was rated with the Hoehn and Yahr (HY) scale and the Unified Parkinson's Disease Rating Scale. Depression was measured with the Montgomery-Asberg Depression Rating Scale. Cognitive impairment and dementia were assessed with the Mini-Mental State Exam and according to diagnostic criteria. Logistic regression analyses were used to investigate associations. At least one NPS occurred in 71% of all patients with PD. The estimated prevalences (ranges) by age group and HY-stage were: depression, 25% (13.2-47.9%), dementia, 29% (12.2-59.4%), and psychotic syndromes, 12.7% (3.1-40.9%). Other frequent complications were sleep disturbances (49%) and anxiety (20%). Depression was associated with gender but not with age. Dementia was associated with age. The rates and comorbidity of depression and dementia were driven by PD severity. NPS were highly prevalent in our comprehensive patient sample,…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Over two-thirds of Parkinson's disease (PD) patients experience comorbid neuropsychiatric symptoms”
From Remote delivery of psychological interventions for Parkinson's disease. (2018) · cites this paper as Riedel et al., 2010
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568 · cited 1×
“The presence of neuropsychiatric symptoms was determined by using a symptom list of selected items from the neuropsychiatric inventory (NPI) (hallucinations, delusions, and anxiety) and the composite international diagnostic interview (CIDI) (sleep disorders/sleep disturbances, paranoid symptoms, and compulsive disord…”
MethodUnified Parkinson's Disease Rating Scale
(2012) · Springer eBooks · doi:10.1007/springerreference_184495 · Cited by 3,071
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Non-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807 · cited 1×
“The increased risk of patients with Parkinson’s disease (PD) for non-motor complications such as dementia, depression, psychotic syndromes, and other neuropsychiatric symptoms (NPS) has been shown in a number of cross-sectional and longitudinal studies [8, 28].”
BackgroundRecent developments in Parkinson's disease
Fahn, S., Elton, R., MARSDEN, C. D., Calne, D. B., & Goldstein, M. (1986) · Raven Press eBooks · Cited by 2,306
Cited by
Sorted by citations
Overdependence on degraded gist memory in Alzheimer's disease.
Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,757
Knaul, F. M., Farmer, P. E., Krakauer, E. L., De Lima, L., Bhadelia, A., Jiang Kwete, X., Arreola-Ornelas, H., Gómez-Dantés, O., Rodriguez, N. M., Alleyne, G. A. O., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32513-8 · Cited by 1,456
Parkinson disease-associated cognitive impairment
Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C. G., Chaudhuri, К. R., & Weintraub, D. A. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00280-3 · Cited by 1,540
Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment
Svenningsson, P., Westman, E., Ballard, C. G., & Aarsland, D. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70152-7 · Cited by 517
Depression and Parkinson’s Disease: Current Knowledge
Marsh, L. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-013-0409-5 · Cited by 434
Kelly, V. E., Eusterbrock, A. J., & Shumway‐Cook, A. (2011) · Parkinson s Disease · doi:10.1155/2012/918719 · Cited by 403
Schäfer, I., von Leitner, E.-C., Schön, G., Koller, D., Hansen, H., Kolonko, T., Kaduszkiewicz, H., Wegscheider, K., Glaeske, G., & van den Bussche, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015941 · Cited by 405
Chahine, L., Amara, A., & Videnovic, A. (2016) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.08.001 · Cited by 306
How might physical activity benefit patients with Parkinson disease?
Speelman, A. D., van de Warrenburg, B. P. C., van Nimwegen, M., Petzinger, G. M., Munneke, M., & Bloem, B. R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.107 · Cited by 296
Depression in neurodegenerative diseases: Common mechanisms and current treatment options
Galts, C., Bettio, L. E. B., Jewett, D. C., Yang, C. C., Brocardo, P. S., Rodrigues, A. L. S., Thacker, J. S., & Gil‐Mohapel, J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.04.002 · Cited by 278
Coelho, M. M., & Ferreira, J. J. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.126 · Cited by 250
Boersma, I. M., Miyasaki, J. M., Kutner, J. S., & Kluger, B. M. (2014) · Neurology · doi:10.1212/wnl.0000000000000674 · Cited by 232
Stress, depression and Parkinson's disease
Hemmerle, A. M., Herman, J. P., & Seroogy, K. B. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.035 · Cited by 225
Psychosis, apathy, depression and anxiety in Parkinson's disease
Gallagher, D. A., & Schrag, A. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.041 · Cited by 211
Du, X., & Pang, T. Y. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00032 · Cited by 221
Cognition Deficits in Parkinson’s Disease: Mechanisms and Treatment
Fang, C., Lv, L., Mao, S., Dong, H., & Liu, B. (2020) · Parkinson s Disease · doi:10.1155/2020/2076942 · Cited by 209
Parkinson’s Disease Psychosis: Presentation, Diagnosis and Management
Schneider, R. B., Iourinets, J., & Richard, I. H. (2017) · Neurodegenerative Disease Management · doi:10.2217/nmt-2017-0028 · Cited by 180
Prange, S., Klinger, H., Laurencin, C., Danaila, T., & Thobois, S. (2022) · Drugs & Aging · doi:10.1007/s40266-022-00942-1 · Cited by 193
Bandelow, B., Baldwin, D. S., Abelli, M., Altamura, C. A., Dell’Osso, B. M., Domschke, K., Fineberg, N. A., Grünblatt, E., Jarema, M., Maron, E., et al. (2016) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1181783 · Cited by 174
Self-citationREM Sleep Behavior Disorder and Cognitive Impairment in Parkinson’s Disease
Jozwiak, N., Postuma, R. B., Montplaisir, J. Y., Latreille, V., Panisset, M., Chouinard, S., Bourgouin, P.-A., & Gagnon, J. (2017) · SLEEP · doi:10.1093/sleep/zsx101 · Cited by 172
Parkinson's disease motor subtypes and mood
Burn, D. J., Landau, S., Hindle, J. V., Samuel, M., Wilson, K., Hurt, C. S., Brown, R. G., & for the PROMS‐PD Study Group (2011) · Movement Disorders · doi:10.1002/mds.24041 · Cited by 149
McDonnell, M. N., Smith, A. E., & Mackintosh, S. F. (2011) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2011.01.021 · Cited by 138
Pain in Parkinson disease: a cross-sectional survey of its prevalence, specifics, and therapy
Buhmann, C., Wrobel, N., Grashorn, W., Fründt, O., Wesemann, K., Diedrich, S., & Bingel, U. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8426-y · Cited by 136
Risk of Parkinson disease after depression
Shen, C., Tsai, S., Perng, C., Kuo, B. I., & Yang, A. C. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a956ad · Cited by 134
Parkinson disease with constipation: clinical features and relevant factors
Yu, Q.-J., Yu, S., Zuo, L.-J., Lian, T., Hu, Y., Wang, R., Piao, Y., Guo, P. F., Liu, L., Jin, Z. Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-16790-8 · Cited by 146
The clinical spectrum of anxiety in Parkinson's disease
Dissanayaka, N. N. N. W., White, E., O'Sullivan, J. D., Marsh, R., Pachana, N. A., & Byrne, G. J. (2014) · Movement Disorders · doi:10.1002/mds.25937 · Cited by 124
Erro, R., Picillo, M., Vitale, C., Amboni, M., Moccia, M., Longo, K., Cozzolino, A., Giordano, F., Rosa, A. D., Michele, G. D., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303419 · Cited by 115
Neuropsychiatric Symptoms in Parkinson’s Disease
Aarsland, D., & Kramberger, M. G. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-150604 · Cited by 105
Erro, R., Pappatà, S., Amboni, M., Vicidomini, C., Longo, K., Santangelo, G., Picillo, M., Vitale, C., Moccia, M., Giordano, F., et al. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.05.022 · Cited by 104
Pupyshev, A. B., Tikhonova, M. A., Akopyan, A. A., Tenditnik, M. V., Dubrovina, N. I., & Короленко, Т. А. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.12.005 · Cited by 107
Memory, Mood, and Vitamin D in Persons with Parkinson's Disease
Peterson, A. L., Murchison, C., Zabetian, C. P., Leverenz, J. B., Watson, G. S., Montine, T. J., Carney, N., Bowman, G. L., Edwards, K. L., & Quinn, J. F. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130206 · Cited by 93
Prevalence of depression in Parkinson's disease: Effects of disease stage, motor subtype and gender
van der Hoek, T. C., Bus, B. A. A., Matui, P., van der Marck, M. A., Esselink, R. A. J., & Tendolkar, I. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.07.007 · Cited by 88
Remote delivery of psychological interventions for Parkinson's disease.
Swalwell, C., Pachana, N. A., & Dissanayaka, N. N. (2018) · International Psychogeriatrics · doi:10.1017/s1041610218000340 · Cited by 87
Mack, J. M., Schamne, M. G., Sampaio, T. B., Pértile, R. A. N., Fernandes, P. A. C. M., Markus, R. P., & Prediger, R. D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3472032 · Cited by 81
Sleep disorders in Parkinson's disease: Many causes, few therapeutic options
Diederich, N. J., & McIntyre, D. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.10.025 · Cited by 80
Effects of exercise on sleep in neurodegenerative disease
Memon, A., Coleman, J., & Amara, A. W. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104859 · Cited by 77
Premotor Diagnosis of Parkinson’s Disease
Reichmann, H. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0159-5 · Cited by 80
Self-citationParkinson Disease and Dementia
Ptacek, S. G., & Kramberger, M. G. (2016) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988716654985 · Cited by 76
Zis, P., Martínez‐Martín, P., Sauerbier, A., Rizos, A., Sharma, J. C., Worth, P. F., Sophia, R., Silverdale, M., & Chaudhuri, К. R. (2015) · European Journal of Neurology · doi:10.1111/ene.12733 · Cited by 71
Parkinson disease-associated cognitive impairment
(2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00286-x · Cited by 73
Fabbri, M., Coelho, M. M., Guedes, L. C., Chendo, I., Sousa, A. C., Rosa, M. M., Abreu, D., Costa, N., Godinho, C., Antonini, A., et al. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.02.007 · Cited by 67
Chopra, A., Tye, S. J., Lee, K. H., Sampson, S. M., Matsumoto, J. Y., Adams, A., Klassen, B. T., Stead, M., Fields, J. A., & Frye, M. A. (2012) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.10070109 · Cited by 65
Thomas, A. J., Taylor, J., McKeith, I. G., Bamford, C., Burn, D. J., Allan, L. M., & O'Brien, J. T. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4609 · Cited by 67
Neuropsychiatric characteristics of GBA-associated Parkinson disease
Swan, M. C., Doan, N., Ortega, R., Barrett, M. J., Nichols, W. C., Ozelius, L. J., Soto‐Valencia, J., Boschung, S., Deik, A., Sarva, H., et al. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.08.059 · Cited by 64
Evidence for gender differences in cognition, emotion and quality of life in Parkinson's disease?
Heller, J., Dogan, I., Schulz, J., & Reetz, K. (2014) · Aging and Disease · doi:10.14366/ad.2014.050063 · Cited by 65
Parkinson’s disease dementia: Diagnostic criteria and risk factor review
Vasconcellos, L. F., & Pereira, J. S. (2015) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2015.1073227 · Cited by 61
Nonmotor Symptoms in Parkinson's Disease
Stacy, M. A. (2011) · International Journal of Neuroscience · doi:10.3109/00207454.2011.620196 · Cited by 61
The impact of Parkinson disease on patients’ sexuality and relationship
Buhmann, C., Dogac, S., Vettorazzi, E., Hidding, U., Gerloff, C. P., & Jürgens, T. P. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1649-8 · Cited by 60
Dubbioso, R., Manganelli, F., Siebner, H. R., & Lazzaro, V. D. (2019) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2019.00111 · Cited by 60
Neurobiology of cognitive impairment in Parkinson’s disease
Jellinger, K. A. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.131 · Cited by 59
Role of Glia in the Regulation of Sleep in Health and Disease
Garofalo, S., Picard, K., Limatola, C., Nadjar, A., Pascual, O., & Tremblay, M. (2020) · Comprehensive physiology · doi:10.1002/cphy.c190022 · Cited by 64
Lai, S., Su, L., Chih‐Hsueh, L. I. N., Chon‐Haw, T. S. A. I., Sung, F., & Hsieh, D. P. H. (2011) · Psychogeriatrics · doi:10.1111/j.1479-8301.2011.00369.x · Cited by 56
Psychiatric issues in cognitive impairment
Aarsland, D., Taylor, J., & Weintraub, D. A. (2014) · Movement Disorders · doi:10.1002/mds.25873 · Cited by 56
Lindström, V., Ihse, E., Fagerqvist, T., Bergström, J. J. E., Nordström, E. K. L., Möller, C., Lannfelt, L., & Ingelsson, M. (2014) · Immunotherapy · doi:10.2217/imt.13.162 · Cited by 56
Parkinson’s Disease and Dementia: A Longitudinal Study (DEMPARK)
Balzer‐Geldsetzer, M., Costa, A. S., Kronenbürger, M., Schulz, J. B., Röske, S., Spottke, A. E., Wüllner, U., Klockgether, T., Storch, A., Schneider, C. B., et al. (2011) · Neuroepidemiology · doi:10.1159/000331490 · Cited by 55
Self-citationBach, J., Riedel, O., Klotsche, J., Spottke, A. E., Dodel, R. C., & Wïttchen, H. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.11.002 · Cited by 54
Self-citationParkinson and depression: review and outlook
Laux, G. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-021-02456-3 · Cited by 52
Diabetes type II: A risk factor for depression-Parkinson–Alzheimer?
Riederer, P., Bartl, J., Laux, G., & Grünblatt, E. (2011) · Neurotoxicity Research · doi:10.1007/s12640-010-9203-1 · Cited by 51
Self-citationDujardin, K., & Sgambato, V. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00025 · Cited by 46
Effort training in Parkinson's disease: A systematic review
Tambosco, L., Percebois-Macadré, L., Rapin, A., Nicomette-Bardel, J., & Boyer, F. C. (2014) · Annals of Physical and Rehabilitation Medicine · doi:10.1016/j.rehab.2014.01.003 · Cited by 56
Frequency of dementia in Parkinson's disease: A systematic review and meta-analysis.
Sousa, C., Alarcão, J., Martins, I. P., & Ferreira, J. (2021) · Journal of Neurological Sciences · doi:10.1016/j.jns.2021.120077 · Cited by 43
Neuropsychiatric symptoms in untreated Parkinson’s disease
Szatmári, S., Illigens, B. M. W., Siepmann, T., Pintér, A., Takáts, A., & Bereczki, D. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s130997 · Cited by 47
Pandey, S., Bajaj, B. K., Wadhwa, A., & Anand, K. S. (2016) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2016.06.014 · Cited by 46
Clinical predictors of cognitive impairment and psychiatric complications in Parkinson’s disease
Campos, L. S., Guimarães, R., Piovesana, L. G., de Azevedo, P. C., dos Santos, L. M. B., & D’Abreu, A. (2015) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20150016 · Cited by 44
Depression and social phobia in essential tremor and Parkinson's disease
Smeltere, L., Kuzņecovs, V., & Erts, R. (2017) · Brain and Behavior · doi:10.1002/brb3.781 · Cited by 44
Physical activity profiles in Parkinson’s disease
Rosen, P., Hagströmer, M., Franzén, E., & Leavy, B. (2021) · BMC Neurology · doi:10.1186/s12883-021-02101-2 · Cited by 41
Cognitive and Neuropsychiatric Features in Parkinson's and Lewy Body Dementias
Fields, J. A. (2017) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acx085 · Cited by 40
Cognitive Behavioral Therapy for Depression and Anxiety in Parkinson's Disease: A Clinical Review
Armento, M. E. A., Stanley, M. A., Marsh, L., Kunik, M. E., York, M. K., Bush, A. L., & Calleo, J. S. (2012) · Journal of Parkinson's Disease · doi:10.3233/jpd-2012-12080 · Cited by 49
Manni, R., Terzaghi, M., Ratti, P., Repetto, A., Zangaglia, R., & Pacchetti, C. (2010) · Consciousness and Cognition · doi:10.1016/j.concog.2010.10.009 · Cited by 38
Bollu, P. C., & Sahota, P. K. (2017) · Europe PMC (PubMed Central) · Cited by 38
Cerebellar atrophy in different subtypes of Parkinson's disease
Ma, X., Su, W., Li, S., Li, C., Wang, R., Chen, M., & Chen, H. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.06.027 · Cited by 41
Hildebrandt, H., Fink, F., Kastrup, A., Haupts, M. R., & Eling, P. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000348350 · Cited by 37
Subjective cognitive decline in idiopathic Parkinson´s disease: A systematic review
Oedekoven, C., Egeri, L., Jessen, F., Wagner, M., & Dodel, R. C. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101508 · Cited by 36
Self-citation“Advanced” Parkinson's disease: A review
Aslam, S., Manfredsson, F. P., Stokes, A. M., & Shill, H. A. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.106065 · Cited by 38
Global Assessment of Palliative Care Need: Serious Health-Related Suffering Measurement Methodology
Kwete, X. J., Bhadelia, A., Arreola‐Ornelas, H., Mendez, O., Rosa, W. E., Connor, S. R., Downing, J. D., Jamison, D. T. T., Watkins, D., Calderón, R., et al. (2024) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2024.03.027 · Cited by 36
Sleep Disorders in Parkinson’s Disease: Clinical Features, Iron Metabolism and Related Mechanism
Yu, S., Sun, L. Z., Liu, Z., Huang, X., Zuo, L., Cao, C.-J., Zhang, W., & Wang, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082924 · Cited by 34
Neuropsychiatric Symptoms in Clinically Defined Parkinson’s Disease: An Updated Review of Literature
Macías-García, P., Rashid-López, R., Cruz-Gómez, Á. J., Lozano-Soto, E., Sanmartino, F., Espinosa‐Rosso, R., & González-Rosa, J. J. (2022) · Behavioural Neurology · doi:10.1155/2022/1213393 · Cited by 34
Morissette, M. P., Prior, H. J., TATE, R. B., Wade, J. G., & Leiter, J. (2020) · Family Medicine and Community Health · doi:10.1136/fmch-2020-000390 · Cited by 34
The risk of developing depression when suffering from neurological diseases
Thielscher, C., Thielscher, S., & Kostev, K. (2013) · Europe PMC (PubMed Central) · doi:10.3205/000170 · Cited by 32
A clinical overview of non-motor symptoms in Parkinson's Disease.
Modugno, N., Lena, F., Biasio, F. D., Cerrone, G., Ruggieri, S. A., & Fornai, F. (2013) · PubMed · Cited by 27
Lackie, R. E., de Miranda, A. S., Lim, M. P., Novikov, V., Madrer, N., Karunatilleke, N. C., Rutledge, B. S., Tullo, S., Brickenden, A. M., Maitland, M. E. R., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02491-8 · Cited by 29
Schamne, M. G., Mack, J. M., Moretti, M., MATHEUS, F. C., Walz, R., Lanfumey, L., & Prediger, R. D. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9912-4 · Cited by 28
Freezing of gait and affective theory of mind in Parkinson disease
Ferrari, A. R. D., Lagravinese, G., Pelosin, E., Pardini, M., Serrati, C., Abbruzzese, G., & Avanzino, L. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.02.023 · Cited by 28
Assessment of cognitive impairment in patients with Parkinson's disease: prevalence and risk factors
Zhang, Z., Wang, Li, Wen, & Xu (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s47367 · Cited by 28
Hong, J. Y., & Lee, P. H. (2022) · Journal of Movement Disorders · doi:10.14802/jmd.22059 · Cited by 29
Riedel, O., Dodel, R. C., Deuschl, G., Klotsche, J., Förstl, H., Heuser, I., Oertel, W. H., Reichmann, H., Riederer, P. F., Trenkwalder, C., et al. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.11.007 · Cited by 27
Self-citationThe relation of sexual dysfunction to depression and anxiety in patients with Parkinson’s disease
Özcan, T. A., Benli̇, E., Demir, E. Y., Özer, F., Kaya, Y., & Haytan, C. E. (2014) · Acta Neuropsychiatrica · doi:10.1017/neu.2014.33 · Cited by 26
Management of anxiety and motor symptoms in Parkinson’s disease
Coakeley, S., Martens, K. A. E., & Almeida, Q. J. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.936388 · Cited by 25
Santos‐García, D., Castro, E. S., Fonticoba, T. D. D., Painceiras, M. J. F., Enríquez, J. G. M., González, J. M. P., Bartolomé, C. C., Planellás, L., Caldentey, J. G., Caballol, N. S., et al. (2020) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988720964250 · Cited by 23
Cognition and Activity of Daily Living Function in people with Parkinson’s disease
Bode, M., Kalbe, E., & Liepelt‐Scarfone, I. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02796-w · Cited by 27
Enders, D., Balzer‐Geldsetzer, M., Riedel, O., Dodel, R. C., Wïttchen, H., Sensken, S.-C., Wolff, B., & Reese, J. (2017) · European Neurology · doi:10.1159/000477165 · Cited by 22
Self-citationClinical EEG in cognitively impaired patients with Parkinson's Disease
Schlede, N., Zimmermann, R., Ehrensperger, M. M., Gschwandtner, U., Hardmeier, M., Hatz, F., Monsch, A. U., Naegelin, Y., & Fuhr, P. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.05.034 · Cited by 22
Kharkar, S., Ellenbogen, J. R., Samuel, M., Rizos, A., Silverdale, M., Chaudhuri, К. R., & Ashkan, K. (2018) · npj Parkinson s Disease · doi:10.1038/s41531-018-0053-5 · Cited by 22
Clinical Epidemiology, Evaluation, and Management of Dementia in Parkinson Disease
Safarpour, D., & Willis, A. W. (2016) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317516653823 · Cited by 21
Depressive Störungen: Major Depression und Dysthymie
Beesdo‐Baum, K., & Wïttchen, H. (2011) · Springer-Lehrbuch · doi:10.1007/978-3-642-13018-2_40 · Cited by 22
Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2
Estanga, A., Rodríguez‐Oroz, M., Ruiz‐Martínez, J., Barandiarán, M., Gorostidi, A., Bergareche, A., Mondragón, E., de Munaín, A. L., & Martí-Massó, J. F. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.07.005 · Cited by 20
Current Progress in the Development of Probes for Targeting α-Synuclein Aggregates
Zeng, Q., & Cui, M. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00877 · Cited by 19
Yang, Y., Yang, Y., Pan, A., Xu, Z., Wang, L., Zhang, Y., Nie, K., & Huang, B. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.878691 · Cited by 19
Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson’s Disease
Angelopoulou, E., Bougea, A. M., Paudel, Y. N., GEORGAKOPOULOU, V. E., Papageorgiou, S. G., & Piperi, C. (2023) · Medicina · doi:10.3390/medicina59061138 · Cited by 19
Driving and dementia: a clinician's guide
Wilson, S., & Pinner, G. (2013) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.111.009555 · Cited by 19
Metadata
- Authors
- Riedel, O., Klotsche, J., Spottke, A., Deuschl, G., Förstl, H., Henn, F., Heuser, I., Oertel, W., Reichmann, H., Riederer, P., Trenkwalder, C., Dodel, R., & Wittchen, H.-U.
- Affiliations
- Technische Universität Dresden (DE)
- University of Bonn (DE)
- Christian-Albrechts-Universität zu Kiel (DE)
- Technical University of Munich (DE)
- Brookhaven National Laboratory (US)
- Charité – Universitätsmedizin Berlin (DE)
- Philipps University of Marburg (DE)
- University Hospital Carl Gustav Carus (DE)
- University of Würzburg (DE)
- Paracelsus Elena Klinik Kassel (DE)
- ORCID
- Venue
- Journal of Neurology
- Published
- 2010-02-06
- Volume
- 257
- Issue
- 7
- Pages
- 1073-1082
- ISSN
- 0012-1037 (ISSN-L)
- 0340-5354
- 1432-1459
- OpenAlex
- W1999630261
- Cited by
- 256
- References
- 41
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 12 · 2023: 8 · 2022: 14 · 2021: 12 · 2020: 48 · 2019: 9 · 2018: 14 · 2017: 19 · 2016: 15 · 2015: 12 · 2014: 22 · 2013: 19 · 2012: 11
- FWCI
- 9.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- Parkinson's disease, neuropsychiatric symptoms, dementia, depression, psychosis, sleep disorders, anxiety, disease severity, prevalence, Hoehn and Yahr stage, outpatients, comorbidities
- MeSH terms
- Aged, Mental Disorders, Dementia, Depressive Disorder, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Outpatients, Parkinson Disease, Comorbidity, Prevalence, Age Distribution, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review